Questo sito utilizza cookie, anche di terze parti, per migliorare la tua esperienza e offrire servizi in linea con le tue preferenze. Chiudendo questo banner, scorrendo questa pagina o cliccando qualunque suo elemento acconsenti all'uso dei cookie.


Forgot your password?
Prodotti per il mercato Italiano
Saliva kits
Hypertension / Calcium Metabolism
Autoimmune Diseases
Diabetes Monitoring
Tumor Markers
Steroids Hormones
Fertility Proteic Hormones
Thyroid Monitoring
Circulating Immuno Complexes
X close

Armored RNA Quant SARS-CoV-2

Armored RNA Quant SARS-CoV-2

CODE 52030 - 52031
Armored technology is a system for producing robust, ribonuclease-resistant RNA controls and standards by assembling specific RNA sequences and viral coat proteins into pseudo-viral partcles.
The RNA can be extracted from the viral coat protein using the same methods used to extract test specimen RNA or by incubating at 75°C for 3 minutes to release the RNA from partcles.
Armored Controls have been utilized in IVD-approved assays for more than 20 years and continue to serve as an important tool in the rapidly evolving space of molecular diagnostics.
In response to the worldwide outbreak of COVID-19, Asuragen has developed a novel Armored RNA control that targets the SARS-CoV-2 viral nucleocapsid (N) region. Our new RNAse P construct aligns with the CDC and WHO recommended Diagnostic Panel (CDC-006-00019) providing a stable, reliable, and safe way to rapidly test for the presence of the novel Coronavirus.
Each control encodes an in vitro transcribed RNA encapsulated in a protective protein coat to create a virus-like particle resistant to nuclease degradation. This allows the products to be used as RNA extraction controls, process quality controls, or positive diagnostic reference controls.
From feasibility to clinical use, these robust and versatile controls are beneficial across all sectors of the research and diagnostic spectrum.
  • Available as standalone catalog items
  • High-quality solution to monitor extraction and process efficiency
  • Compatible with a wide range of RNA-based clinical assays
  • Non-infectious, synthetic constructs simplify shipping and storage
  • Deployable as extractable, exogenous internal positive control
  • Tailored sequences specific to SARS-CoV-2 and RNAse P
  • Degradation resistant in majority of biological matrices
  • Multiple volume and manufacturing options available
  • Available as cGMP or development lot in a range of fill volumes
  • Concentration determined using National Institute of Standards (NIST)traceable standard
  • Highly standardized, quality controlled manufacturing ensures reliabilityand consistency between lots
  • Manufactured in a cell-free system

Download Brochure - Armored RNA Quant Sars-CoV-2.pdf

DiaMetra srl Unipersonale

p.iva 12585340156


Via Pozzuolo, 14 - 06038 Spello - Perugia Italy
T +39.0742.24.851 +39.0742.30.19.29
F +39.0742.31.61.97
Management and Coordination : Immunodiagnostic Systems (IDS) Ltd, Boldon-UK
DiaMetra | © All rights reserved 2011